SCHEMBL13867604

SCHEMBL13867604

CCOC[C@]1(C)CC[C@H](n2ccc(N)nc2=O)O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 3/20 0.43
LMNA P02545 3/20 0.43
CACNA1F O60840 2/20 0.43
ALB P02768 2/20 0.43
MAPT P10636 2/20 0.43
CACNA1D Q01668 2/20 0.43
CACNA1S Q13698 2/20 0.43
CACNA1C Q13936 2/20 0.43
PDE4D Q08499 1/20 0.38
SLC29A1 Q99808 1/20 0.38
THRB P10828 1/20 0.37
MTOR P42345 1/20 0.37
MDM2 Q00987 1/20 0.37
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
POLG P54098 2/20 0.37
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.34
POLA1 P09884 1/20 0.34
FGFR1 P11362 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12840917 0.85 PDE3A (0.51) PDE3ALMNACACNA1FALBMAPT
SCHEMBL23171503 0.80 POLG (0.58) PDE3ALMNACACNA1FALBMAPT
SCHEMBL13674373 0.78 PDE3A (0.47) PDE3ALMNACACNA1FALBMAPT
SCHEMBL13081934 0.76 PDE3A (0.41) PDE3ALMNACACNA1FALBMAPT
SCHEMBL10083556 0.76 PDE3A (0.49) PDE3ALMNACACNA1FALBMAPT
SCHEMBL20879460 0.76 PDE3A (0.47) PDE3ALMNACACNA1FALBMAPT
SCHEMBL20879469 0.76 PDE3A (0.42) PDE3ALMNACACNA1FALBMAPT
SCHEMBL9149041 0.75 PDE3A (0.48) PDE3ALMNACACNA1FALBMAPT
SCHEMBL12061109 0.75 PDE3A (0.48) PDE3ALMNACACNA1FALBMAPT
SCHEMBL10438149 0.75 PDE3A (0.48) PDE3ALMNACACNA1FALBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118223-A1 Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives MERCK SHARP & DOHME CORP. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118223-A1 Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives MTAP, NT5C3B, NSUN2 PDE3A 369/4885LMNA 2163/4885CACNA1F 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.